Phil Engel
Operations manager over distribution and manufacturing. Outside of work I read the research on health and longevity, lifting, MMA, the markets, and AI — and I write up what I find.
Infographics
All 34 →Evidence-honest summaries of health and medical topics — what the trials show and what practising physicians report, including where they disagree. Every claim is sourced.
Nandrolone (Deca-Durabolin): The 1962 FDA-Approved Anemia Drug Bodybuilders Never Gave Back
Nandrolone (Deca) is a 1962 FDA-approved anabolic steroid — never withdrawn for safety, still Schedule III, still made by zero US manufacturers — with a genuinely…
MOTS-c: The "Exercise in a Vial" Peptide — 247 Papers, Zero Completed Human Trials, One That Just Started
MOTS-c is a mitochondrial-derived peptide marketed as 'exercise in a vial' — 247 papers of strong preclinical metabolic and exercise-mimetic data, but zero completed…
The Mitochondrial Triple Stack: MOTS-c + SS-31 + NAD+ — What's Actually Tested vs. What's Taught
The MOTS-c + SS-31 + NAD+ 'mitochondrial stack' — separating the real trial evidence behind each component from the marketing that bundles them into one protocol.
SS-31 (Elamipretide): The Peptide That Failed Four Trials and Got Approved for $800,000 a Year
SS-31 (elamipretide/Bendavia) is a cardiolipin-binding mitochondrial peptide with strong preclinical mechanism data — but four separate placebo-controlled human RCTs…
Low-Dose Naltrexone (LDN) in Cancer — What the Case Series, Mechanisms, and Missing Trials Actually Show
LDN at 1.5–4.5 mg nightly is used off-label as a cancer adjunct. Preclinical OGF-OGFr and immune data are consistent across models; human evidence is sparse: a Duke…
Epithalon (Epitalon): The Pineal Tetrapeptide — Telomerase, Telomeres & the Longevity Question
Epithalon (Ala-Glu-Asp-Gly, AEDG) is a synthetic pineal tetrapeptide with 150+ PubMed papers and a credible cell-line telomerase story — but zero placebo-controlled…
Recently added videos
newest across every category
